All News
#ACR21 - I don't remember the final count from ACR20, but 23k tweets🐦and 78.6 Million🔥 impressions have to be some type of record. @rheum_cat with over 1,600 tweets and counting. Don't forget the 𝐀𝐂𝐑𝟐𝟏 𝐓𝐰𝐞𝐞𝐭 𝐔𝐩 (𝟖𝐌𝟓𝟐𝟎) today at 6:00 PM. https://t.co/8qEMiorQCo
Steven Echard, CAE StevenEchard ( View Tweet)
Join us now at the #ACR21 #COVID19 community hub to hear Kevin Winthrop and @RADoctor discussing about vaccines in patients with RMDs
#ACRAmbassador https://t.co/LivAoLu810
Alessia Alunno alessia_alunno ( View Tweet)
Alcohol and MTX don't go along!
In a cohort of 1000+ early RA
Factors associated w/
1️⃣Nausea
Female OR 2
🍺 Alcohol OR 1.44
DAS28CRP OR 1.16
2️⃣Alopecia
Age OR 4.87
🍺 Alcohol OR 1.98
HAQ score OR 1.62
#Abst1444 #ACR21 @RheumNow https://t.co/zZG6aFR1SX
Aurelie Najm AurelieRheumo ( View Tweet)
👉HCQ dose < 400 mg/d are assc with SLE flare. Lower doses of HCQ may decrease risk of retinopathy. 👉For >80 kg (176 lbs), any dose < 400 mg/day is assc with increased odds of flare
(HCQ blood levels not measured)
Abst#1462 #ACR21 @rheumnow https://t.co/5tx3kruT8W
TheDaoIndex KDAO2011 ( View Tweet)
I will be at the Early Career community Hub in 5 minutes (at 5pm Eastern) with @DanielHSolomon discussing "How to Get Published" #ACR21
Jeffrey Sparks MD MMSc jeffsparks ( View Tweet)
Dr. Furie thinks that pulse IV steroids are more effective than oral high dose steroids. If you use pulse IV, you can then use a lower oral dose of prednisone w/faster taper. Will he mandate pulse IV steroids w/his next trial? ...long pause.. No. #ACR21 @rheumnow
TheDaoIndex KDAO2011 ( View Tweet)
CBD for pain in hand OA/inactive PsA:
- works in animal models (many things do)
- other neg RCTs didn't use CBD itself
- DBRCT: 12w continuous, n=136, min dropout
Result:
does absolutely nothing
I bet big money it will be tried again & again
@Joner_MD #ACR21 ABST1456 @RheumNow https://t.co/lZLVrgrKST
David Liew drdavidliew ( View Tweet)
Dr Vela presents DB RCT on cannabidiol in hand OA and PsA. No effect seen. Abstr#1456 #ACR21 @RheumNow https://t.co/ck2eUx5Elz
Richard Conway RichardPAConway ( View Tweet)
The opening of #ACR21 Convergence was a hit for all who signed up and viewed in. The day included the presidential address by outgoing president Dr. David Karp (UT Southwestern) and a keynote talk and interview with Dr. Seema Yasmin (Stanford).
Read more..
https://t.co/m98lrjFgS4 https://t.co/vKpCEDJiyx
Links:
Dr. John Cush RheumNow ( View Tweet)
COVID in Rheumatologic Disease Patients: Drs. Sparks, Liew, Yazdany and Dao provide an update on data specific to COVID in rheumatologic disease patients.
@jeffsparks @drdavidliew @KDAO2011
#ACR21
https://t.co/IzDIpe5IrU https://t.co/6i8C3Grw9q
Links:
Dr. John Cush RheumNow ( View Tweet)
apart from that, fibrosis is fascinating - as is the potential for a shared fibrotic pathway
#ACR21 Antifibrotics session @RheumNow https://t.co/FXbhBx9sJ1
David Liew drdavidliew ( View Tweet)
@ericdeinmd Although the MTX/alopecia - nausea poster was interesting. Abst#1444 #ACR21
Factors assc w/MTX- nausea/alopecia:
👉female sex
👉EtOH use
👉higher disease activity
👉belief that the med will cause it
(older age assc w/⬇️risk of nausea) https://t.co/XDKFhvN0V1
@rheumnow
TheDaoIndex KDAO2011 ( View Tweet)
#ACR21 Ab#1445. RTX & #covid19 outcomes
⭐️RTX ass. w/ Upwards arrow COVID hospitalization, ICU admission, and ventilation
▶️We need huge caution in pts that have not been vax'ed before RTX 💉💉
@Rheumnow
https://t.co/6UNUVhnBkI https://t.co/vHkQe9fZpI
Links:
Eric Dein ericdeinmd ( View Tweet)
#ACR21 Ab#1036.
Rheum is often the field of uncertainty. @zach_wallace_md shows uncertainty correlates w/ depression, anxiety, sickness impact across rheum diseases
⭐️Is uncertainty something to target as intervention?
@Rheumnow https://t.co/v9kbk2hCqO https://t.co/50ELS3ZQp9
Links:
Eric Dein ericdeinmd ( View Tweet)
So what do we do with Iberdomide data? Tough to analyze re 2nd half of yr1 and uncertainty of dose response Abst#1458 #ACR21 @RheumNow v low placebo response 35% Interesting https://t.co/JXnoJTy2tv
Janet Pope Janetbirdope ( View Tweet)
Among 6 CV risk algorithms, the best to predict the carotid plaque (CP) in PsA is the ACC/AHA risk score showed an AUC 0.681 (0.551-0.812), p=0.008, a cut-off point ≥4.8, sensitivity of 63.6%, and specificity of 64.4%
⭐️Prevalence CP 42.3%
Abst #1315 #ACR21 @RheumNow https://t.co/hRvyjetYq3
swethaann23 swethaann23 ( View Tweet)
I thought pirfenidone was just an anti-fibrotic - the spectrum of its MOA is actually fascinating
@ErinWilfongMD #ACR21 Antifibrotics session, chaired by @JuliePaikMD @RheumNow https://t.co/oMZOtfAUq0
David Liew drdavidliew ( View Tweet)
RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow & its faculty.
Dr. John Cush RheumNow ( View Tweet)
DCVAS testing results in GCA. @davidliew @philipcrobinson are you guys essentially not imaging anyone in anyway? What's going on? #ACR21 @RheumNow https://t.co/IMr5ee2Iea
Richard Conway RichardPAConway ( View Tweet)
Billing and coding expert, Jean Acevedo shares the three URLs that you need to best understand the updated 2021 EM coding! #ACR21 @RheumNow #RheumNow https://t.co/3HbDuZP8gC
Dr. Rachel Tate uptoTate ( View Tweet)